Skip to content

VIPS-MRI

Validation of bi-dimensional (2D) and three dimensional (3D)Fourier Decomposition as Magnetic Resonance Imaging technique to assess lung ventilation and perfusion compared to computed tomography (CT) Hyperpolarised Gases and contrast enhanced MRI: a pilot study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON24322
Enrollment
16
Registered
2017-11-21
Start date
2018-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cystic fibrosis

Interventions

VIPS-MRI ( max 2x) and for healthy controls flow volume curve

Sponsors

Erasmus MC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CF patients • Diagnosed with CF with sweat and genetic testing • Age years 12-18 years • Scheduled for biennial CT scan • Willing and capable to perform spirometer controlled chest MRI • Informed consent Healthy Volunteers • Siblings or friends of the CF participants • Age 12-18 years (age and gender matched to CF patients) • Willing and capable to perform spirometer controlled chest MRI • Informed consent

Exclusion criteria

Exclusion criteria: All • MRI contraindication (i.e. cardiac pacemaker, metallic implant, hearing aids, etc.) • Claustrophobic • Pregnancy • Not willing or unable to perform MRI CF Patients • Recent (< 1 month) RTE with use of i.v. antibiotics • Chronic oxygen therapy • Any other severe comorbidities that could limit imaging Healthy volunteers • Recent (< 1 month) history of lung disease (i.e. pneumonia) • Known history of chronic lung disease (i.e. asthma) • Known history of congenital lung disease (i.e. bronchopulmonary dysplasia, tracheomalacia)

Design outcomes

Primary

MeasureTime frame
To validate 2D and 3D FD as technique to assess lung ventilation compared to CT and PFT outcomes related to lung ventilation.

Secondary

MeasureTime frame
• To develop and standardize the VIPS MRI platform • To develop semi-quantitative and quantitative image analysis methods for the most clinical relevant VIPS outcome measures including outcome measures derived from fused images

Contacts

Public ContactH Tiddens

Erasmus MC Sophia

h.tiddens@erasmusmc.nl010 7036263

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)